Europe's Liquid Biopsy Market Predicted to Surge, Forecasted to Reach $5.58 Billion by 2033 [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
5 min read Company Logo European Liquid Biopsy Market European Liquid Biopsy Market Dublin, Feb. 17, 2025 (GLOBE NEWSWIRE) -- The "Europe Liquid Biopsy Market: Focus on End User and Country - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering. The European liquid biopsy market, valued at $1.24 billion in 2024, is expected to reach $5.58 billion by 2033, exhibiting a robust CAGR of 18.18% during the forecast period 2024-2033. In Europe, liquid biopsy is a new non-invasive diagnostic technique that is transforming cancer detection and surveillance. This method has the potential to early detect cancer recurrence or evaluate treatment responses, and it provides real-time monitoring with minimal invasiveness. The growing prevalence of cancer, rising research publications, and clinical trials are some of the factors driving the growth of the liquid biopsy market. These factors are creating higher demand for liquid biopsy tests and produ
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Syndromic Multiplex Diagnostics Market Size to Hit USD 4.13 Billion by 2032, Growing at a CAGR of 4.71% - SNS Insider [Yahoo! Finance]Yahoo! Finance
- QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million [Yahoo! Finance]Yahoo! Finance
- QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 MillionBusiness Wire
- Qiagen (NYSE:QGEN) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Are Investors Undervaluing Qiagen N.V. (NYSE:QGEN) By 24%? [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 11/4/25 - Beat
QGEN
Sec Filings
- 11/12/25 - Form SCHEDULE
- 11/6/25 - Form 6-K
- 11/6/25 - Form 6-K
- QGEN's page on the SEC website